Biomaterial Database

[Nonspecific therapy of acute infectious diarrhea]. 1984

K Gyr

The non-specific therapy of acute infectious diarrhoea is outlined with regard to the mechanism of action and effectiveness. Special attention is given to rehydratation therapy and oral rehydration mainly. Among the groups of adsorbents, agents acting on intestinal flora and agents interfering at the toxin receptor site, Bismuth-subsalicylate is about the only substance with a proven efficacy.

UI	MeSH Term	Description	Entries
D007239	Infections	Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.	Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007422	Intestines	The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.	Intestine
D011971	Receptors, Immunologic	Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.	Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002792	Cholestyramine Resin	A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion.	Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D003131	Combined Modality Therapy	The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.	Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003967	Diarrhea	An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.	Diarrheas
D005440	Fluid Therapy	Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS.	Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006162	Guanylate Cyclase	An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2.	Guanyl Cyclase,Deoxyguanylate Cyclase,Guanylyl Cyclase,Inosinate Cyclase,Cyclase, Deoxyguanylate,Cyclase, Guanyl,Cyclase, Guanylate,Cyclase, Guanylyl,Cyclase, Inosinate
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074261	Receptors, Enterotoxin	Guanylate cyclase-coupled receptors that bind bacterial ENTEROTOXINS, as well as the endogenous peptides guanylin and uroguanylin. Ligand binding stimulates production of CYCLIC GMP by EPITHELIAL CELLS of the intestinal lumen, altering barrier permeability and mucus secretion. Mutations in the gene (GUCY2C) encoding this receptor are associated with some cases of hereditary diarrhea (Diarrhea 6) and MECONIUM ILEUS.	Enterotoxin Receptor,Enterotoxin Receptors,Enterotoxin-Guanylin Receptor,Enterotoxin-Guanylin Receptors,GC-C Receptor,GC-C Receptors,Guanyl Cyclase-C Receptor,Guanyl Cyclase-C Receptors,Guanylin-Uroguanylin Receptor,Guanylin-Uroguanylin Receptors,Guanylyl Cyclase C,Heat-Stable Enterotoxin Receptor,Heat-Stable Enterotoxin Receptors,Receptor, Enterotoxin,Receptor, Guanyl Cyclase-C,Receptors, Guanyl Cyclase-C,Cyclase C, Guanylyl,Cyclase-C Receptors, Guanyl,Enterotoxin Guanylin Receptor,Enterotoxin Guanylin Receptors,Enterotoxin Receptor, Heat-Stable,Enterotoxin Receptors, Heat-Stable,GC C Receptor,GC C Receptors,Guanyl Cyclase C Receptor,Guanyl Cyclase C Receptors,Guanylin Uroguanylin Receptor,Guanylin Uroguanylin Receptors,Heat Stable Enterotoxin Receptor,Heat Stable Enterotoxin Receptors,Receptor, Enterotoxin-Guanylin,Receptor, GC-C,Receptor, Guanyl Cyclase C,Receptor, Guanylin-Uroguanylin,Receptor, Heat-Stable Enterotoxin,Receptors, Enterotoxin-Guanylin,Receptors, GC-C,Receptors, Guanyl Cyclase C,Receptors, Guanylin-Uroguanylin,Receptors, Heat-Stable Enterotoxin